About: Irina Robu
- Website
- http://tissueengineering.wordpress.com
- Details
- Scientist - chemical engineering, bioengineering of stem cells, biomaterials; photographer, traveler....
Posts by Irina Robu:
-
November 19, 2020 The complication of Pfizer’s Vaccine Distribution’s Plan
-
November 18, 2020 Regeneron’s new antibody cocktail drug, REGN-COV2
-
November 15, 2020 First-ever living 3D-printed aneurysm
-
October 18, 2020 The lessons from the Covid-19 response, according to Anthony Fauci
-
October 13, 2020 Detecting SARS-COV-2 antibodies in serum and plasma samples
-
October 13, 2020 Connecting the Immune Response to Amyloid-β Aggregation in Alzheimer’s Disease via IFITM3
-
October 11, 2020 Tiny biologic drug to fight COVID-19 show promise in animal models
-
October 11, 2020 Llama-inspired “AeroNabs” to strangle COVID-19 with an inhaler
-
October 9, 2020 AI-controlled sensors could save lives in smart hospitals and homes
-
October 9, 2020 Noninvasive blood test can detect cancer years before conventional diagnosis
Follow Blog via Email
Join 2,041 other subscribers-
Recent Posts
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
- Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
- Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
Archives
Categories
Meta